India markets close in 1 hour 47 minutes

LifeSci Acquisition II Corp. (LSAQ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.94-0.02 (-0.20%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.96
Open9.94
Bid0.00 x 800
Ask0.00 x 900
Day's range9.89 - 10.00
52-week range9.77 - 12.68
Volume139,918
Avg. volume93,009
Market cap99.512M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
    GlobeNewswire

    LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination

    NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today announced the confidential submission with the U.S. Securities and Exchange Commission (“SEC”) of a draft registration statement on Form S-4 (the “Registration Statement”) relating to its previously announced proposed business combination with Science 37, Inc. About LifeSci Acquisition II Corp. L

  • SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger
    GlobeNewswire

    SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger

    WILMINGTON, Del., May 12, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating LifeSci Acquisition II Corp. (“LifeSci”) (NASDAQ GS: LSAQ) regarding possible breaches of fiduciary duties and other violations of law related to LifeSci’s agreement to merge with Science 37, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-lifesci-acquisition-ii-corp. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising. Prior results do not guarantee a similar outcome. CONTACT: Rigrodsky Law, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com

  • Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law Firm
    GlobeNewswire

    Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law Firm

    NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Monmouth Real Estate Investment Corporation (NYSE: MNR) Monmouth has agreed to merge with Equity Commonwealth. Under the proposed transaction, Monmouth shareholders will receive $19.58 in cash per share. Live Oak Acquisition Corp. II (NYSE: LOKB) Live Oak II has agreed to merge with Navitas Semiconductor. Under the proposed transaction, Live Oak II shareholders will only own 18.1% of the combined company. LifeSci Acquisition II Corp. (NASDAQ : LSAQ) LifeSci II has agreed to merge with Science 37. Under the proposed transaction, LifeSci II shareholders will retain ownership of only 6.2% of the combined company. Mackinac Financial Corporation (NASDAQ: MFNC) Mackinac has agreed to merge with Nicolet Bankshares. Under the proposed transaction, Mackinac shareholders will receive 0.22 shares of Nicolet common stock and $4.64 in cash per share. Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at jkuehn@moorekuehn.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Moore Kuehn is a 5-star Google rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts:Moore Kuehn, PLLCJustin Kuehn, Esq.30 Wall Street, 8th FloorNew York, New York 10005jkuehn@moorekuehn.com(212) 709-8245